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Abstract
Clostridium difficile is an emergent pathogen, and the most common cause of nosocomial diarrhea. In an effort to
understand the role of small noncoding RNAs (sRNAs) in C. difficile physiology and pathogenesis, we used an in silico
approach to identify 511 sRNA candidates in both intergenic and coding regions. In parallel, RNA–seq and differential 59-end
RNA–seq were used for global identification of C. difficile sRNAs and their transcriptional start sites at three different growth
conditions (exponential growth phase, stationary phase, and starvation). This global experimental approach identified 251
putative regulatory sRNAs including 94 potential trans riboregulators located in intergenic regions, 91 cis-antisense RNAs,
and 66 riboswitches. Expression of 35 sRNAs was confirmed by gene-specific experimental approaches. Some sRNAs,
including an antisense RNA that may be involved in control of C. difficile autolytic activity, showed growth phase-dependent
expression profiles. Expression of each of 16 predicted c-di-GMP-responsive riboswitches was observed, and experimental
evidence for their regulatory role in coordinated control of motility and biofilm formation was obtained. Finally, we detected
abundant sRNAs encoded by multiple C. difficile CRISPR loci. These RNAs may be important for C. difficile survival in
bacteriophage-rich gut communities. Altogether, this first experimental genome-wide identification of C. difficile sRNAs
provides a firm basis for future RNome characterization and identification of molecular mechanisms of sRNA–based
regulation of gene expression in this emergent enteropathogen.
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Introduction
In recent years, the importance of regulatory mechanisms based
on the action of RNA molecules became widely appreciated. In
bacteria, regulatory RNAs play a critical role in adaptive responses
and in various metabolic, physiological, and pathogenic processes.
In particular, small noncoding RNAs (sRNAs) have been recently
identified in many pathogenic bacteria [1–3]. Such sRNAs rely on
a variety of mechanisms to control their targets, including i) direct
binding to low-molecular weight effector molecules (riboswitches);
ii) binding to proteins; iii) interaction with double-stranded DNA
or RNA (CRISPR, clustered regularly interspaced short palin-
dromic repeats RNAs); and iv) RNA/RNA duplex formation with
mRNA targets [4]. Riboswitches are cis–acting elements com-
monly involved in the control of vitamin, amino acid, and
nucleotide base biosynthesis gene expression in bacteria. Upon
interaction with ligands (usually the products of biosynthetic
operons they control), riboswitches undergo a conformational
change leading to positive or negative effects on transcription
termination or translation [5]. Protein-binding sRNAs often
directly antagonize the function of their targets [6,7]. For example,
the widely distributed 6S RNA acts as a promoter decoy for RNA
polymerase holoenzyme containing major sigma 70 factor by
mimicking an open promoter complex and globally regulating
transcription during adaptation to stationary phase of growth [7].
CRISPR RNAs contain short regions of complementarity to
bacteriophage and plasmid sequences. In complex with Cas
proteins, CRISPR RNAs interfere with bacteriophage infection
and plasmid invasion by recognizing foreign DNA and targeting it
for destruction [8]. The largest and most extensively studied set of
sRNA regulators acts by modulating the translation and/or
stability of specific mRNA targets in response to changes in the
environment [9]. These regulatory RNAs can be divided into cis-
encoded RNAs, which are transcribed from a DNA strand
opposite to the one from which mRNA to be regulated is
transcribed and are thus fully complementary to their targets
[10,11], and trans-encoded RNAs, which are transcribed from
separate loci and are only partially complementary to target
mRNAs [9]. In many cases, the RNA-chaperone Hfq protein is
required for trans-encoded sRNA-mediated control [12].
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With the exception of recent identification of cyclic-di-guanosyl-
59monophosphate (c-di-GMP) riboswitches [13–15], no experi-
mental data on regulatory RNAs in Clostridium difficile has been
reported. However, recent genome-wide in silico searches for
sRNAs within intergenic regions (IGRs) [16–18] suggested that
riboregulators may be abundant in clostridia including C. difficile
and could be involved in the control of metabolism and virulence.
In Clostridium perfringens, four sRNAs controlling expression of
toxin-encoding genes were experimentally identified [19–21],
including VirX, which was the first clostridial regulatory RNA
discovered by Ohtani and Shimizu [20,21]. In Clostridium
acetobutylicum, we have recently described a novel mechanism of
control of a sulfur metabolic operon by an antisense RNA [22].
C. difficile is an anaerobic spore-forming bacterium that is a
major cause of nosocomial infections associated with antibiotic
therapy. This enteropathogen can lead to antibiotic-associated
diarrhea and pseudomembranous colitis, a potentially lethal
disease. Transmission of C. difficile is mediated by contamination
of the gut by its spores. The disruption of colonic microflora by
antimicrobial therapy precipitates colonization of the intestinal
tract by C. difficile and ultimately leads to infection [23]. After spore
germination, vegetative forms multiply and major virulence
factors, the two large toxins, TcdA and TcdB, are produced
causing alterations in the actin cytoskeleton of intestinal epithelial
cells [24]. Many aspects of C. difficile infection cycle, including the
identification of additional virulence and colonization factors and
the determination of molecular mechanisms controlling their
production in response to environmental signals, still remain
poorly understood [25,26]. We hypothesize that sRNAs may
contribute to these important processes.
To systematically search for regulatory RNAs in C. difficile, we
here used a robust in silico approach that has been successfully
applied for the identification of sRNAs in Escherichia coli and
Streptococcus agalactiae [27]. This led to the identification of a large
number of sRNA candidates in both intergenic and coding regions
of the C. difficile genome. RNA-seq and differential 59-end RNA-
seq approaches were then used to validate these predictions and to
globally identify C. difficile sRNAs and their transcriptional start
sites. In this way, the expression of numerous sRNAs located in
IGRs and representing potential trans riboregulators, cis-antisense
RNAs, riboswitches, and CRISPR RNAs was detected. The
expression of several sRNAs was independently confirmed by
gene-specific approaches, and potential involvement of some of
them in growth-stage specific control in C. difficile was revealed.
This study thus constitutes a basis for the future detailed functional
characterization of RNA-based regulatory mechanisms in C.
difficile.
Results/Discussion
Identification of putative sRNA candidates by in silico
approach in C. difficile genome
Predicted C. difficile Rho-independent terminator (RIT) sites,
which often terminate sRNA gene transcription, were used as a
starting point for an in silico sRNA search according to a method
previously described for S. agalactiae [27]. In the 4,290,252-bp
genome of C. difficile strain 630, 2644 putative RIT sites were
found. To identify the transcription termination signals associated
with sRNA genes, we filtered out the RIT sites associated with
protein coding genes (i.e., located within 225 to +60 nt of stop
codons of preceding open reading frames (ORFs)) as well as the
RIT sites with calculated free Gibbs energy DG037.24 kcal/mol.
sRNA gene candidates located antisense to coding sequences
(CDSs) were filtered out if DGu37 of their RIT sites was more than
28 kcal/mol. The conservation of remaining sequences and the
presence of covariations in predicted RNA secondary structure
elements of RIT was next analysed using comparison with
available clostridial sequences in GenBank database. sRNA
candidates were then scored on the basis of their RIT score,
which was weighted by the number of covariation pairs found.
Threshold DG037 values of 24 kcal/mol or 28 kcal/mol and a
requirement for at least two covariations, including one in the RIT
stem left 511 sRNA candidates (257 sRNAs in IGRs and 254
antisense RNAs) that were classified according to their position
relative to adjacent CDSs. These predicted sRNAs are summa-
rized in Table 1 and a detailed list of sRNA candidates (named
from ‘‘SQ1’’ to ‘‘SQ2610’’) is given in Table S1. A recent study
searching for potential sRNAs in IGRs in clostridial genomes that
combined comparative genomics with promoter and RIT
predictions [16] identified 264 sRNA candidates in the C. difficile
630 strain. The comparison of our data with the previous study
revealed 95 IGRs containing common potential sRNAs
(Figure 1A). The strategy of Chen et al [16] does not detect
potential regulatory RNAs located antisense to known CDSs. 147
such sRNAs were predicted by our method alongside with 107
additional antisense RNAs overlapping 59 or 39 untranslated
regions of C. difficile genes (Table 1, Figure 1B).
Experimental detection of sRNAs by RNA–seq and 59-end
RNA–seq
High-throughput sequencing of cDNA allows strand-specific
identification of transcripts with single-nucleotide resolution. For
several bacterial species, such deep sequencing technologies
revealed an unexpected transcriptome complexity and identified
a large number of novel sRNAs [28,29]. For genome-wide
detection of expressed sRNAs in C. difficile, we combined two
independent sequencing approaches - whole-transcript cDNA
sequencing (RNA-seq) and differential 59-end sequencing (59-end
RNA-seq allowing global identification of transcriptional start sites
(TSS)). The RNA-seq analysis was performed with RNAs
extracted from C. difficile 630Derm strain after 6 h of growth (late
exponential phase). For 59-end sequencing, we mixed three
Author Summary
The emergent human pathogen Clostridium difficile is a
major cause of nosocomial diarrhea associated with
antibiotic therapy. During the last few years, severe forms
of C. difficile infections became more frequent due to the
emergence of hypervirulent isolates. Despite intensive
studies, many questions regarding the mechanisms con-
trolling C. difficile virulence remain unanswered. We
hypothesized that C. difficile, a member of an ancient
group of bacteria, might widely use ancestral RNA–based
mechanisms to control its gene expression for better
adaptation to host conditions. Indeed, using next-gener-
ation sequencing technology, we identified a great
number and a large diversity of potential RNA regulators
in this pathogen. We obtained experimental evidence for
regulatory roles of a particular class of regulatory RNAs
responding to c-di-GMP, a universal bacterial signaling
molecule regulating motility, biofilm formation, and
virulence. We also detected abundant small RNA products
of recently discovered adaptive prokaryotic immunity
CRISPR-Cas systems that might be important for C. difficile
survival in gut communities. Our findings suggest that
small RNA molecules may play a major role in regulatory
processes during C. difficile infection cycle and as such are
promising targets of new therapeutic strategies.
sRNA Genome-Wide Identification in C. difficile
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different RNA samples extracted from cells harvested in
exponential growth phase (4 h of growth), at the onset of
stationary phase (10 h of growth), and under nutrient starvation
conditions. For RNA-seq, a non-orientated whole-transcript
library was generated from late exponential phase RNA sample
depleted for sRNAs. For 59-end RNA-seq, two strand-specific
cDNA libraries were generated from mixed RNA sample depleted
for rRNAs. The first library was constructed from RNA sample
treated with Tobacco Acid Pyrophosphatase (TAP+) allowing
inclusion of reads associated with the TSS. A second library was
constructed from the same RNA sample without TAP treatment
(TAP2). The libraries were subjected to Illumina sequencing
yielding a total of 37 million of whole-transcript reads (RNA-seq)
and a total of 75.5 million and 38 million of 59-end reads for TAP+
and TAP2 libraries (59-end RNA-seq), respectively. After removal
of reads mapping to rRNA genes, about 6 to 10% of total reads
were mapped to the genome of C. difficile strain 630 (for details see
Table S2). For TSS identification, the sequencing data were
compared between TAP+ and TAP2 libraries. This approach
allowed us to identify 251 TSSs upstream of potential sRNA
genes. 66 TSSs are located upstream of riboswitches and 185
upstream of other sRNAs (Table 1). Within the latter group, 94
Figure 1. Comparative analysis of sRNAs identified in this study by comparative genomics and bioinformatics and by deep
sequencing with those predicted in IGR in previously published study. Venn diagram representations of the number of sRNAs in IGR (A) and
antisense RNAs to CDSs (B) identified by our bioinformatics analysis (in blue), predicted by previously published in silico analysis (in yellow) [16] and
experimentally observed in our deep sequencing data (in pink).
doi:10.1371/journal.pgen.1003493.g001
Table 1. Summary of sRNA candidates in C. difficile.
Method of detection Total IGR Antisense CDS Antisense 39UTR Antisense 59UTR
In silico prediction 511 257 147 79 28
Confirmation by RT-PCR 28 19 4 5 0
Confirmation by Northern blot 9 8 1 0 0
Confirmation by deep sequencing (RNA-seq and/or TSS mapping) 68 46 10 9 3
Deep sequencing Total IGR Cis-antisense
sRNAs
Riboswitches
Predicted in silico 126 46 22 58
New 125 48 69 8
Total regulatory RNAs 251 94 91 66
sRNA localization: IGR, intergenic region; antisense CDS, sRNA antisense to coding sequence, antisense 39UTR, antisense overlapping the 39untranslated region of CDS;
antisense 59UTR, antisense overlapping the 59untranslated region of CDS.
doi:10.1371/journal.pgen.1003493.t001
sRNA Genome-Wide Identification in C. difficile
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sRNAs are encoded within IGRs and may therefore represent trans
RNA regulators, while 91 sRNAs are transcribed in an antisense
direction to coding regions and may therefore represent cis RNA
regulators (Table 1, Table S3). Potential riboswitches were first
defined as sRNAs having a characteristic RNA-seq profile and
TSS located at a significant distance from a downstream coding
gene, usually with a metabolic function. The riboswitch nature of
most of these RNAs was further confirmed by Rfam search (see
below).
Some of the 185 non-riboswitch sRNAs identified by deep
sequencing were also predicted by the in silico analysis (Figure 1).
The incomplete overlap between experimental sRNA detection
and bioinformatics predictions has been already noted in other
studies [30,31]. This may be due to a requirement for a particular
growth condition for expression of some of in silico predicted
sRNAs, the restriction of bioinformatics predictions to sRNAs
conserved in closely related species, the RIT criteria eliminating
sRNAs derived from 39-ends of coding genes, or the presence of
false positive candidates among in silico predictions. We preserved
the SQ names for in silico-predicted sRNA candidates (Table S1)
and named additional sRNA candidates identified by deep
sequencing according to their position in the genome, from
CD630_n00010 to CD630_n01130 in agreement with recently
published C. difficile gene nomenclature [32] (Table S3).
Experimental validation of sRNA candidates
We confirmed several selected sRNAs predicted in silico and/or
identified by deep sequencing using gene-specific experimental
approaches: reverse-transcription-PCR (RT-PCR) and Northern
blot analysis. Expression of selected sRNAs was monitored under
different growth conditions of C. difficile 630Derm cultures to reveal
the cases of growth phase-dependent expression. To determine if
selected sRNAs are also present in another C. difficile strain, we
extracted RNA from a PCR-ribotype 027 hypervirulent strain
(R20291) during late exponential growth phase and also subjected
it to analysis.
RT-PCR analysis revealed that 28 out of 30 in silico predicted
sRNA candidates were transcribed in strain 630Derm during the
exponential growth phase and/or at the onset of stationary phase.
A representative example of experimental validation of five sRNA
candidates expression by RT-PCR is presented in Figure S1.
Expression of 9 and 7 out of 13 in silico predicted sRNA candidates
in strain 630Derm and R20291, respectively, was detected by
Northern blotting. Figure 2 shows a representative result for four
sRNAs predicted in silico and detected by RNA-seq in both strains.
As can be seen, Northern blot analysis with probes specific for
SQ1002 candidate sRNA revealed an abundant ,200-nt tran-
script, which agrees well with the 236-nt in silico predicted length
and the 151-nt length deduced from RNA-seq data. For SQ1985
(predicted length of 233-nt), a much shorter, ,70-nt low-
abundance transcript was detected in accordance with the 84-nt
length revealed from RNA-seq data. The discrepancy in lengths
may be explained by in silico prediction criteria (maximum size
limit fixed at 250 nt) as well as the fact that predictions did not
take in account the positions of promoters. No growth phase
dependence was observed for the expression of sRNA candidates
tested. However, examples of growth phase-dependent regulation
of C. difficile sRNAs will be discussed later in the text.
Among the 185 C. difficile 630Derm sRNAs identified by deep
sequencing, 35 out of 40 candidates assayed were detected by
Northern blotting of 630Derm strain RNA samples, while 23 were
detected in RNA prepared from the R20291 strain samples.
Transcript lengths agreed well with the sizes deduced from RNA-
seq approach (Figure 2, Figure 3, Figure 4, Figure 5, Figure 6,
Figure 7, Figure 8; Figures S2, S3, S4, S5) and were confirmed by
independent 59/39RACE analysis for 4 selected RNAs (Table S4).
59RACE experiments unambiguously identified TSSs for eight
potential sRNAs and were in complete agreement with the TSSs
identified by 59-end RNA-seq (Table S4).
We identified TSS of antisense transcripts in genes required for
flagella synthesis, encoding prophage proteins, transcriptional
regulators, and membrane proteins (Table S3). Generally, the
expression of cis-antisense RNAs was more difficult to detect than
that of sRNAs located in IGRs. Figure 3 shows representative
examples of each regulatory RNA type detected in 630Derm and
R20291 strains: an IGR (CD630_n00660, named RCd1), a cis-
antisense (CD630_n00030, named RCd2), and a riboswitch
(Cdi2_4). The RCd1 sRNA is transcribed from IGR between
CD1894 and CD1895 genes encoding conserved hypothetical
proteins. An abundant transcript of about 100-nt was stably
detected under all tested conditions by Northern blotting
(Figure 3A). Interestingly, the presence of two additional less
abundant longer transcripts was consistent with the detection of
possible processing sites downstream from the TSS in 59-end
RNA-seq analysis (indicated by arrows in Figure 3A). The RCd2
RNA is transcribed in antisense orientation to the 39UTR of
CD0182 encoding a conserved hypothetical protein. As can be
seen from Figure 3B, two major transcripts of about 150 and
350 nt in length were detected. The type II c-di-GMP riboswitch
(Cdi2_4) is located upstream of a pilin encoding gene CD3513
(Figure 3C) [14]. A major transcript of about 100 nt was detected
in Northern blot together with two additional less abundant 160-nt
and 200-nt transcripts (Figure 3C). The role of RCd2 and Cdi2_4
sRNAs is discussed later in the text.
Overall, the results of validation of in silico prediction and deep
sequencing indicate that both approaches are valuable and robust
tools for identification of sRNAs in C. difficile. Since each method
has its own advantages and disadvantages, the combination of
both approaches appears to be optimal for the systematic detection
of sRNAs. However, focusing only on predicted sRNAs confirmed
by RNA-seq is too restrictive since a number of potentially
interesting candidates was identified by deep sequencing alone.
The presence of multiple validated sRNAs from different
riboregulator families demonstrates the diversity and wide spread
use of RNA-mediated control in C. difficile.
Features of sRNAs
We analysed the nucleotide sequences upstream of experimen-
tally identified sRNA TSSs to search for promoters. In most cases,
we detected sequences matching the 210 or 210 and 235
promoter consensus elements recognized by the RNA polymerase
sigma A holoenzyme (Table 2). However, since promoter elements
recognized by the 22 other sigma factors encoded in the C. difficile
genome are still poorly defined, transcription of sRNAs by other
holoenzymes is possible and deserves further investigation.
Since small proteins of less than 50 amino acids have been
largely disregarded in genome annotations [33], one cannot
exclude that some sRNAs identified in this study encode short
proteins or peptides. We therefore searched for ORFs within our
sRNA sequences collection. 73 sRNAs encoding at least one
putative ORF of more than 15 amino acids were identified. Since
some sRNAs contained multiple ORFs, the total number of
putative sRNA-encoded ORFs is 106. However, only 9 sRNAs
contained a predicted start codon connected to a reasonably
located recognizable putative ribosome binding-site (RBS), while
11 sRNAs contained only a questionable RBS (Table 2). 13 of
these 20 ORFs were conserved in all 14 sequenced C. difficile
strains (Table 2). Comparative genomic analysis showed that only
sRNA Genome-Wide Identification in C. difficile
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7 sRNA-encoded sequences were similar to fragments of known
proteins. The similarity was due to an overlap of these sRNAs with
39ends of adjacent protein-encoding genes. Therefore, we
conclude that most of identified C. difficile sRNAs are unlikely to
encode small proteins. Nevertheless, definitive exclusion of peptide
encoding by corresponding DNA regions needs further experi-
mental verification.
We next used the Rfam database (a collection of noncoding
RNA families) to search for C. difficile sRNAs similar to known
sRNAs [34]. The summary of this analysis is given in Table 2. For
the majority of IGR and cis-antisense C. difficile sRNAs, no
functional class can be assigned suggesting that they may represent
novel sRNA regulators. As expected for relatively understudied
Gram-positive bacterium C. difficile, only few identified sRNAs
corresponded to known functional classes. Among them,
CD630_n00410 (RCd3) sRNA matches the housekeeping 6S
RNA and CD630_n00840 corresponds to selenocysteine tRNA. A
total of 24 annotated tRNAs were also detected by deep
sequencing. 12 other highly expressed sRNAs originated from C.
difficile CRISPR cassettes (see below). Most of identified regulatory
RNAs for which a functional class can be assigned correspond to
riboswitches. Thus, in addition to 16 c-di-GMP-dependent
riboswitches carrying either GEMM RNA or c-di-GMP II motif
[14,15], we could predict a function for 39 of remaining
riboswitches (Table 2, Table S3). T-box antitermination is one
of the main mechanisms controlling amino acid biosynthesis in
Gram-positive bacteria [35,36]. Accordingly, 20 C. difficile RNA
regulatory elements detected in our RNA-seq analysis correspond-
ed to T-box riboswitches. We also detected that all of the 5
predicted SAM-riboswitches and all of the 4 predicted L-box
riboswitches are located upstream of genes involved in methionine
biosynthesis or uptake [37] and in lysine biosynthesis and transport
[38], respectively. In addition, we detected several known
ribozymes including 8 group I introns upstream of transposase
genes and a ribozyme corresponding to RNase P of type A (Table
S3).
Figure 2. Experimental validation of in silico identified sRNAs. Northern blot was performed for detection of selected sRNAs: SQ367, SQ1002,
SQ1985 and SQ2025. RNA samples were extracted from 630Derm strain grown at exponential phase (E, 4 h of growth), late exponential phase (LE, 6 h
of growth), entry to stationary phase (S, 10 h of growth) or under nutriment starvation conditions (St) and from R20291 strain grown at late
exponential phase (LE). 5S RNA at the bottom serves as loading control. The arrows show the detected transcripts with their size estimated by
comparison with RNA molecular weight standards.
doi:10.1371/journal.pgen.1003493.g002
sRNA Genome-Wide Identification in C. difficile
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In accordance with Northern blot results general BLAST
analysis revealed that about 80% of all C. difficile 630Derm
sRNAs detected by deep sequencing were also present in the
hypervirulent R20291 strain, which has about 80% genome
sequence similarity with the 630 strain [39]. To better explore
the conservation of sRNAs within the C. difficile species, we used
BLAST to analyse the distribution of sRNAs among available C.
difficile genomes. The results revealed that most sRNAs are
conserved, with 69 IGR sRNAs being present in all 14
sequenced C. difficile strains (Table 2, Table S5). Moreover, 32
conserved riboswitches were identified upstream of orthologous
genes in all 13 annotated C. difficile genomes. Finally, the
sequences homologous to 60 cis-antisense RNAs were also found
in all C. difficile strains. However, for cis-antisense RNAs this
analysis was partially biased by the overlap with conserved
coding sequences. Nevertheless, the high degree of conservation
of the sRNAs identified among the C. difficile strains emphasizes
their functional importance in this bacterium.
We next extended the analysis of sRNA conservation to other
clostridia. Less stringent BLAST searches (alignment restriction
length lowered from 80 to 50% of sRNA length) revealed that only
few of C. difficile sRNA genes are present in at least one other
clostridial species (Table S5). Two IGR sRNAs, CD630_n01090
and CD630_n00840, are found in C. perfringens and C. sticklandii.
Two antisense RNAs, CD630_n00090 and SQ771, are found in
C. beijerinckii, and in C. botulinum, C. ljungdahlii, C. perfringens, and C.
tetani, respectively, but are located within conserved coding
sequences. Our apparent inability to detect homologues of most
sRNAs in clostridia is somewhat contradictory to conclusions from
previously published in silico analysis [16], which showed that
about half of predicted clostridial sRNAs in IGRs are conserved
among most clostridial species. However, in accordance with
previous studies, the conservation of some riboswitches was
revealed. Only few sRNA candidates were conserved outside
Clostridia (Table S5). Obviously, further work will be necessary to
experimentally detect and catalogue regulatory RNAs in other
Figure 3. Detection of selected sRNAs by RNA–seq, 59-end RNA–seq, and Northern blot. A representative example of 59-end RNA-seq
(TAP-/TAP+ profile comparison), RNA-seq and Northern blot detection of sRNA located in IGR (A); cis-antisense RNA (B) and riboswitch (C). On a RNA-
seq and 59-end RNA-seq sequence read mapping visualization, coding sequences are indicated by blue arrows and new sRNA candidates identified in
this study are indicated by grey arrows. The 59-end RNA-seq data for both strands are presented in upper and lower parts of B panel. The TSS
identified by 59-end RNA-seq are indicated by red broken arrows in accordance with the positions of 59-transcript ends shown by vertical green lines
on the sequence read graphs corresponding either to TSS (broken arrows) or to processing sites (vertical arrows). The TSS corresponds to position
with significantly greater number of reads in TAP+ sample, potential cleavage site corresponds to position with large number of reads in both TAP2
and TAP+ samples. 59-end RNA-seq data show 51-bp reads matching to the 59-transcript ends, while RNA-seq data show reads covering whole
transcript. For Northern blot analysis, RNA samples correspond to those indicated for Figure 2. 5S RNA at the bottom serves as a loading control. The
arrows show the detected transcripts with their estimated size.
doi:10.1371/journal.pgen.1003493.g003
sRNA Genome-Wide Identification in C. difficile
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clostridial species. The regulatory RNAs revealed in this work for
the most part are unique to C. difficile and could be associated with
specific physiopathology of this bacterium.
Examples of RNA potentially involved in regulatory
functions
Below, we present a more detailed analysis of several C. difficile
sRNAs belonging to different functional classes of riboregulators
including IGR sRNAs, cis-antisense RNAs, riboswitches, and
CRISPR RNAs.
Identification of C. difficile 6S RNA. C. difficile expressed
one abundant not previously annotated sRNA (CD630_n00410,
RCd3) corresponding to the widely distributed housekeeping 6S
RNA. The TSS identified by our 59-end RNA-seq analysis is
preceded by consensus 235 and 210 promoter elements of the
sigma A RNA polymerase holoenzyme (Figure 4A, Figure S2).
Two RCd3 probe-hybridizing bands, of about 200 and 175 nt,
were detected by Northern blotting (Figure 4B) as also observed in
Bacillus subtilis and S. pneumoniae [40,41]. These bands might
correspond to a primary transcript and a processed form of C.
difficile 6S RNA. Secondary structure prediction by Mfold [42]
indicated that C. difficile RCd3 RNA can adopt a characteristic 6S
RNA structure mimicking the structure of DNA in open promoter
complex (Figure 4C) and tightly binding to the RNA polymerase
holoenzyme [7,43]. 6S RNA is present in various clostridial
genomes. Our study provides the first experimental validation of
the 6S sRNA expression in clostridia further confirming that
global regulation of RNA polymerase activity by this sRNA is a
widely conserved mechanism.
sRNAs regulated by growth phase. The synthesis of
virulence factors in C. difficile is growth phase-dependent
[26,44,45]. In particular, the entry into stationary phase is a
signal that triggers expression of pathogenic determinants includ-
ing toxins or adhesion and colonization factors [46]. Expression of
six sRNAs detected by Northern blotting was growth phase-
dependent (Table 3). Three sRNAs (CD630_n00210 (RCd4),
CD630_n00680 (RCd5), and SQ1002) were induced at the onset
of stationary phase, whereas the expression of three others
(CD630_n00030 (RCd2), CD630_n00170 (RCd6), and SQ1498)
was high during exponential phase and decreased at the onset of
stationary phase. Figure 5 shows two examples of growth phase-
regulated sRNAs: RCd6 located in the IGR between CD0469 and
CD0470 genes encoding a saccharose-type IIABC component of
the PTS system and a beta-lactamase-inducing penicillin-binding
protein (BlaR), respectively, and SQ1498 located in IGR between
CD2112 and CD2113 genes encoding a conserved hypothetical
protein and a two-component sensor histidine kinase, respectively
(Figure 5A). For RCd6 and SQ1498, ,100 and 150-nt transcripts
were detected by Northern blotting in accordance with sizes
deduced from RNA-seq data (Figure 5B, Figure S3). Quantitative
real-time PCR (qRT-PCR) analysis showed that RCd6 and
SQ1498 were, respectively, 12- and 10-fold more abundant during
exponential growth than in stationary phase (Table 3).
For four out of six growth phase-regulated sRNAs, the sigma A-
dependent promoters were identified upstream of the TSS
determined by 59-end RNA-seq and confirmed by 59RACE or
59/39RACE (Table 3, Table S4), while only a 210 promoter
element is present upstream of SQ1498. The presence of sigma A
recognition sequences suggests that growth phase-dependent
control of transcription of these sRNAs does not involve the
recruitment of RNA polymerase holoenzyme containing alterna-
tive sigma factors like SigH, the key C. difficile sigma factor during
the transition phase [45]. Interestingly, we observed a 3-fold up-
regulation of SQ1498 and a 7-fold down-regulation of RCd5 in a
sigH mutant compared to 630Derm strain suggesting an indirect
control by SigH. Two transcriptional regulators that control pre-
or post-exponential events have been described in C. difficile:
CodY, a global regulator monitoring the nutrient sufficiency of the
environment [44] and Spo0A, a response regulator involved in the
initiation of sporulation [47]. Only RCd6 was down-regulated
about 2-fold in the spo0A mutant (data not shown). Thus, the
mechanisms of regulation of these six growth-phase dependent C.
difficile sRNAs remain to be determined.
With the exception of a c-di-GMP-dependent riboswitch, the
search with Rfam database did not allow us to assign a function for
Figure 4. Detection and secondary structure prediction of abundant 6S RNA. In RCd3 (6S RNA) genomic region (A) coding sequences are
indicated by blue arrows and the 6S RNA is indicated by a grey arrow. For Northern blot analysis (B) RNA samples correspond to those indicated for
Figure 2. 5S RNA at the bottom serves as loading control. The arrows on the right show the detected transcripts with their estimated size. (C) The RNA
secondary structure prediction was performed by Mfold software. Central asymmetric bubble mimicking open promoter structure and conserved
short stem-loop structure on one side of this bubble are underlined in orange. Two generally conserved G-C base pairs surrounding this structure are
indicated by arrows.
doi:10.1371/journal.pgen.1003493.g004
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the growth phase-regulated C. difficile sRNAs (Table 3). Since four
growth phase-regulated sRNAs are encoded in IGRs, they may
regulate their targets in trans by base-pairing with 59UTRs of target
genes mRNAs or coding regions. Three available softwares (see
Materials and Methods section) predicted several common
potential mRNA targets for each of these sRNAs. However, the
relevance of these predictions needs further experimental inves-
tigations. Interestingly, secondary structure prediction by Mfold
revealed that both growth phase-regulated sRNAs RCd6 and
SQ1498 are highly structured. In RCd6, the predicted target base-
pairing region is located in a bubble within the predicted
secondary structure and might be therefore available for target
interaction (Figure 5B). To test the effect of overexpression or
depletion of these two growth phase-regulated sRNAs on the
abundance of predicted target gene mRNAs, we constructed C.
difficile strains carrying sRNA regions in sense or antisense
orientation under the control of inducible Ptet promoter of the
pRPF185 vector derivative (Table S6). In the presence of the ATc
inducer, up to 100-fold increase of RCd6 and SQ1498 sRNA
levels was detected by qRT-PCR (data not shown). However, no
detectable effects on the putative target genes mRNA levels or
significant changes in C. difficile growth were observed (data not
shown). One possibility would be that RCd6 and SQ1498 might
affect the expression of their target genes at the translational
initiation level as commonly found for known trans riboregulators
[9]. Alternatively, in silico predictions may have failed to identify
true RCd6 and SQ1498 targets. So, additional experiments will be
required to assess the function of these sRNAs and their
mechanisms of action.
The RCd2 sRNA is down-regulated at the onset of stationary
phase. It is transcribed in an antisense orientation to two adjacent
genes CD0182 and CD0183 and overlapped the 39-end of CD0182
(a gene of unknown function) and the 59-end of CD0183 (encodes a
putative cell wall hydrolase) (Figure 3B and Figure 6A). Northern
blotting reveals two major transcripts (,150 and 350 nt),
hybridizing with an RCd2-specific probe (Figure 6C). Identifica-
tion of the RCd2 sRNA ends by 59/39RACE confirmed the
position of TSS identified by 59-end RNA-seq and precisely
positioned the 39-ends 175 nt and 350 nt downstream from TSS.
Thus, both RCd2 transcripts overlap by 53 nt with the CD0183
mRNA, while only the longer RCd2 transcript overlaps by 108 nt
with the coding region of CD0182 (Figure 3B and Figure 6A,
Table S4). Overexpression of RCd2 led to a dramatic growth
defect (Figure 6B), prompting us to analyse this RNA in more
Figure 5. Expression analysis and secondary structure prediction of growth phase-regulated sRNAs. The results are given at the left for
RCd6 sRNA and at the right for SQ1498. In corresponding genomic region (A) coding sequences are indicated by blue arrows and new sRNA
candidates identified in this study are indicated by grey arrows. For Northern blot analysis (B) RNA samples correspond to those indicated for Figure 2
for 630Derm strain. 5S RNA at the bottom serves as loading control. The arrows show the detected transcripts with their estimated size. The RNA
secondary structure prediction was performed by Mfold software. The loop region of predicted target interaction for RCd6 is highlighted in orange.
doi:10.1371/journal.pgen.1003493.g005
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detail. C. difficile strains 630/p (carries the pRPF185 vector), 630/
pRCd2 (overexpresses RCd2 from the Ptet inducible promoter of
pRPF185), and 630/pAS-RCd2 (overexpresses RCd2 in antisense
orientation) (Table S6) grew equally well in TY medium in the
absence of ATc inducer. In the presence of inducer, the doubling
time of 630/pRCd2 increased more than 3-fold compared to that
of 630/p or 630/pAS-RCd2 (Figure 6B and data not shown). The
growth yield of 630/pRCd2 strain in the presence of ATc was also
greatly reduced. A qRT-PCR analysis showed up to 300-fold
induction of RCd2 expression in 630/pRCd2 compared to 630/p.
Northern blot analysis of RNA extracted from induced 630/
pRCd2 strain revealed several abundant major transcripts of
about 105, 150, and 350 nt that hybridized with a RCd2-specific
probe (Figure 6C). Similar transcripts were detected in 630Derm or
630/p strains (Figure 6C).
The effect of RCd2 overexpression on possible target genes was
analysed by Northern blots with probes specific for CD0182 or
CD0183. While the CD0182 mRNA was indetectable at conditions
used, we observed a band of about 1000-nt with the CD0183-
specific probe corresponding to the expected mRNA length
(Figure 6C). Interestingly, this transcript was more abundant in
630/pRCd2 strain compared to 630/p. The apparent positive
effect of RCd2 overexpression on the abundance of the CD0183
transcript was further confirmed by qRT-PCR (.9-fold increase
in 630/pRCd2 compared to 630/p). One hypothesis would be
that the possible base-pairing between the 59-parts of RCd2 RNA
and CD0183 mRNA (Figure 6A, 6D) may stabilize the target
mRNA by protecting it from ribonucleolytic attacks. Several
bacterial sRNAs are known to activate target gene expression by
direct or indirect mechanisms including translational activation
Figure 6. Effect of RCd2 RNA overexpression on target gene control. (A) Sequence of RCd2 RNA within CD0182 and CD0183 IGR. The TSS
‘‘+1’’ for antisense RNA and CD0183 mRNA identified by 59-end RNA-seq are indicated by broken arrows. The 59- and 39-ends of RCd2 RNA identified
by 59/39RACE are shown in bold and are indicated by stars and in grey boxes, respectively. The 210 and 235 regions are boxed. The transcriptional
terminator for RCd2 is indicated by convergent arrows. The CD0182 and CD0183 start codons and the CD0182 stop codon are shown in black. The
ribosome binding site (RBS) of CD0183 is inderlined. The numbers indicate positions relative to the CD0183 TSS. (B) Growth of 630/p strain (triangles)
and 630/pRCd2 strain (squares) in TY medium at 37uC in the presence (open symbols) or absence (closed symbols) of 250 ng/mL ATc. (C) Effect of
RCd2 overexpression on the CD0183 transcript abundance. For Northern blot analysis, RNA samples were extracted from 630Derm strain during
exponential growth phase (E, 4 h of growth), at the onset of stationary phase (S, 10 h of growth) and from 630/p control strain or from 630/pRCd2
strain overexpressing RCd2 grown at late exponential growth phase (LE) in the presence of 250 ng/mL ATc (630/p, 630/pRCd2). Detection with RCd2-
specific probe is shown on the left and with CD0183-specific probe on the right. 5S RNA at the bottom serves as loading control. Longer exposure
time was required for better detection of RCd2 transcripts in 630Derm and 630/p strains. The RNA secondary structure prediction (D) was performed
by Mfold software. The terminator at the 39-end and loop region at the 59-end overlapping 59-part of CD0183 mRNA are highlighted in orange.
doi:10.1371/journal.pgen.1003493.g006
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and mRNA stabilization [48,49]. However, further experiments
would be needed to precisely determine the molecular mechanism
of this sRNA action.
Interestingly, the CD0183 gene encodes a putative cell wall
hydrolase that shares 38% identity with a L. monocytogenes autolysin,
which promotes bacterial infection in vivo and modulates the
interaction with the host immune system [50,51], and 28%
identity with B. subtilis LytE autolysin involved in cell wall
turnover, cell separation during vegetative growth, and heat
survival [52,53]. The severe growth deficiency observed upon
RCd2 overexpression may be explained by postulating that
increased abundance of the CD0183 transcript leads to enhanced
cell autolytic activities as suggested by the presence of cell debris
observed by optic microscopy (data not shown). Indeed, CD0183
overexpression leads to growth defect in E. coli and C. difficile (data
not shown). Thus, RCd2 sRNA may represent an example of
RNA-dependent control of autolysin function in C. difficile.
Coordinated regulationby c-di-GMP riboswitches inC. difficile
Another class of riboregulators detected by our analysis includes
riboswitches responding to c-di-GMP. C-di-GMP is a signaling
molecule with important functions in microbiological systems
controlling lifestyle switches from free-living motile state to biofilm
communities and virulence in Gram-negative bacteria [54]. The c-
di-GMP molecule is synthesized from 2 GTP by diguanylate
cyclases and is degraded into pGpG or 2GMP by phosphodies-
terases. Effector molecules bound by this messenger include
transcriptional factors and other proteins on the one hand, and
RNA molecules that act as riboswitches on the other hand [55]. In
contrast to most Gram-positive bacteria including some closest
relatives, C. difficile encodes a large number of c-di-GMP turnover
enzymes (up to 37) [56]. In addition, 12 type I c-di-GMP specific
riboswitches (c-di-GMP-I) carrying conserved GEMM RNA
domain [15] and 4 type II c-di-GMP dependent riboswitches (c-
di-GMP-II) carrying a distinct RNA motif triggering an allosteric
Figure 7. Functional analysis of c-di-GMP riboswitches in C. difficile. (A) Northern blot detection of SQ173 located upstream of the flgB
flagella operon. Coding sequences are indicated by blue arrows and SQ173 is indicated by a grey arrow. For Northern blot analysis, RNA samples
correspond to those indicated for Figure 2. 5S RNA at the bottom serves as loading control. The arrow on the left shows the detected transcripts with
their estimated size. (B) Effect of overexpression of CD1420 (dccA) encoding diguanylate cyclase on motility and biofilm formation. A representative
result of motility and biofilm formation assay of strains 630/pdccA (pRPF185-CD1420) and 630/p (pRPF185) performed in the absence or in the
presence of ATc (500 ng/mL) inducing the expression of the CD1420 gene. qRT-PCR data show fold change for 630/pdccA/630/p ratio for the flgB
gene positively regulated by Cdi1_3 riboswitch, flagellin-encoding fliC gene and CD3513, CD2831 genes negatively regulated by c-di-GMP
riboswitches of type II. Northern blot analysis of c-di-GMP-I (C) and c-di-GMP-II (D) riboswitches. RNA samples correspond to those indicated for
Figure 6, 630/p and 630/pdccA strain RNA samples were extracted at late exponential growth phase (LE) in the presence of 500 ng/mL ATc. White
arrows correspond to target gene full-length transcripts and black arrows to premature terminated transcripts and processed forms (C) or stable
spliced forms (D).
doi:10.1371/journal.pgen.1003493.g007
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self-splicing ribozyme activity have been predicted in C. difficile
[13,14].
RNA-seq detected the expression of all C. difficile c-di-GMP
riboswitches (Table S7). The analysis of chromosomal organiza-
tion of the regions carrying c-di-GMP riboswitches revealed
several interesting features. Two adjacent genes CD2830 (encodes
a precursor of exported protein) and CD2831 (encodes a precursor
of a collagen-binding protein) are controlled by c-di-GMP-I and c-
di-GMP-II riboswitches (Cdi1_12 and Cdi2_3), respectively. Two
c-di-GMP-I riboswitches (Cdi1_4 and Cdi1_5) are located in
distant loci within the C. difficile 630 genome in highly similar
prophage regions (CD0904-979 and CD2889-2952) corresponding
to host cell lysis module of bacteriophage PhiCD119. Therefore, c-
di-GMP may control two homologous prophage genes CD2889
and CD0977.1. Four other regions carrying c-di-GMP-I ribos-
witches (Cdi1_8, Cdi1_9, Cdi1_10 and Cdi1_11) are also highly
homologous to each other (from 88 to 93% nucleic acid sequence
identity) and must have arisen through multiple duplication events.
They are located upstream of genes encoding conserved hypo-
thetical proteins of unknown function (CD1990.3, CD2309,
CD1424 and CD3368.2, respectively).
Functionality of c-di-GMP type I riboswitches. One c-di-
GMP-I riboswitch (Cdi1_3) is found upstream of the large flgB
operon involved in the synthesis of basal body, hook and motor
components of flagella and flagella specific sigma factor, SigD
[15]. The presence of this regulatory RNA element within the
59UTR of flgB was predicted in silico (SQ173 RNA) and
experimentally confirmed by RNA-seq (Table S3). The precise
location of the flgB TSS was determined by 59-end RNA-seq data
and further confirmed by 59RACE (Table S4, Figure S4, Table
Figure 8. Expression of CRISPR 16 cassette. The structure of CRISPR 16 and CRISPR 15 cassettes on C. difficile strain 630 chromosomal region is
schematically shown (A) with spacers indicated as rectangles numbered according to the transcription order and repeats indicated as diamonds.
Regions corresponding to CRISPR 15 and CRISPR 16 cassettes are indicated by grey arrows. The TSS with ‘‘leader’’ region is indicated by red arrow.
The position of the oligonucleotide complementary to the first spacer sequence of CRISPR 16 locus used as probe for Northern blot is indicated by
black arrow. CRISPR cassette is transcribed into a single RNA transcript (pre-crRNA), which is cleaved by the Cas proteins to generate small CRISPR
RNAs (crRNAs), each containing one spacer. Spacers match foreign DNA and this recognition lead to interference process resulting in bacterial cell
protection. For Northern blot analysis (B), RNA samples were extracted from 630Derm strain grown at exponential phase (E), late exponential phase
(LE), entry to stationary phase (S) or under nutriment starvation conditions (St). 5S RNA serves as loading control. Arrows indicate full-length pre-
crRNA transcripts, incompletely processed crRNAs and crRNAs with their estimated size.
doi:10.1371/journal.pgen.1003493.g008
Table 2. Features of sRNA candidates identified by RNA–seq.
IGR sRNAs (94) Cis-antisense sRNAs (91) Riboswitches*** (66)
Predicted promoters 33 sigma A promoters 63 sigma A promoters 13 sigma A promoters (c-di-GMP I, c-di-GMP II)
Presence of putative CDSs 48 (9 RBS, 9 ? RBS; 11 conserved
ORFs*)
22 (2 ? RBS; 2 conserved
ORFs*)
3
Function prediction by Rfam
database
1 6S; 1 tRNA-Sec; 12 CRISPR-DR14;
1 tmRNA
20 T-box [36]; 5 SAM [37]; 3 FMN; 4 Lysine [38]; 1
TPP; 2 Purine; 2 Glycine; 1 Cobalamin; 12 c-di-GMP
I (GEMM RNA motif) [15]; 4 c-di-GMP II [13,14]; 2
ykkC-yxkD-like leader
Conservation among 14
C. difficile strains
69 60** 32****
‘‘RBS’’ Shine Dalgarno sequence for ribosome binding site, ‘‘? RBS’’, questionable ribosome binding site.
*Conservation of ORFs among 14 sequenced C. difficile strains. RNA sequences were analysed for matches in a collection of RNA families Rfam database (http://rfam.
sanger.ac.uk/).
**The analysis for cis-antisense RNA was biased by the conservation of overlapping coding sequences.
***Riboswitches responding to S-adenosyl methionine (SAM), flavin mononucleotide (FMN), thiamine pyrophosphate (TPP).
****CD37 genome without gene annotation was excluded from this analysis.
doi:10.1371/journal.pgen.1003493.t002
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S7). In accordance with the RNA-seq pattern, Northern blotting
with the SQ173-specific probe revealed the presence of a major
,160-nt transcript corresponding to premature termination of
transcription upstream of the flgB operon (Figure 7A, Figure S4). It
is intriguing that the promoter is located 496 bp upstream of the
flgB start codon and that the terminated transcript is rather small
(160 nt). However, by gene-specific RT-PCR we have clearly
demonstrated the co-transcription of Cdi1_3 with flgB (Figure S4).
The role of this long 59UTR of flgB deserves further investigation.
To analyse the relevance of c-di-GMP signaling in C. difficile, we
cloned the CD1420-dccA gene encoding a c-di-GMP synthetase
[57], under the control of the inducible Ptet promoter of plasmid
pRPF185 (Table S6). In the presence of inducer, the CD1420
transcript level was up to 1000-fold higher in strain 630/pdccA
carrying pRPF185-CD1420 than in strain 630/p carrying the
pRPF185 vector. We therefore infer that the level of c-di-GMP
should be considerably higher in induced 630/pdccA than in the
control strain or in the absence of induction as demonstrated
independently with another system of expression [57]. In
accordance with the presence of a c-di-GMP riboswitch upstream
of the flgB flagella assembly operon, the overexpression of CD1420
led to a severe decrease of motility (Figure 7B). In addition, qRT-
PCR analysis revealed a three-fold decrease in expression of flgB
and fliC genes in induced 630/pdccA strain compared to 630/p
(Figure 7B). The fliC gene encoding the main structural
component of flagella filament, flagellin, is located within a
distinct operon that might be indirectly controlled by c-di-GMP
for example via fliA, a gene encoding flagella-specific sigma factor
SigD, required for flagella gene expression in other bacteria and
located within the flgB operon.
To further demonstrate the functionality of c-di-GMP ribos-
witches in C. difficile, we used the CD1420-overexpressing 630/
pdccA strain to analyse the effect of c-di-GMP levels on gene
expression by Northern blotting and qRT-PCR (Figure 7C and
7D, Table S7). For c-di-GMP type I riboswitches Cdi1_9 and
Cdi1_12, two different transcripts were detected by Northern
blotting with riboswitch-specific probes, the smaller ones corre-
sponding to premature termination of transcription and the longer
ones corresponding to transcripts of targeted genes, CD2309 or
CD2830, respectively. Excess c-di-GMP should bind to the leader
region of mRNA at the riboswitch motif, leading to premature
termination of transcription and decrease in transcriptional read-
through necessary for full-length mRNA production. Indeed, upon
induction of CD1420 expression in 630/pdccA, we observed the
repression of CD2309 and CD2830 full-length transcripts com-
pared to strain 630/p (Figure 7C). Interestingly, in strain 630/
pdccA, we observed in addition to a terminated transcript of 140 nt
(Cdi1_9) or 170 nt (Cdi1_12) smaller bands with higher intensities
that may represent the products of ribonucleolytic cleavage of the
terminated transcript initiated in the presence of high c-di-GMP
concentrations. Indeed, specific ribonucleases including RNase Y,
RNase P, RNases J1 and J2 have been shown to cleave
riboswitches or T-box motifs to initiate their ligand-dependent
turnover in several bacteria [58–60]. The homologous RNase
genes are present in C. difficile genome and may be also involved in
riboswitch processing. Finally, a more general qRT-PCR analysis
revealed the c-di-GMP-dependent negative control for all but one
of the 12 c-di-GMP type I riboswitches in C. difficile (Table S7).
This ‘‘OFF’’ riboswitch function corresponding to premature
termination of transcription in the presence of elevated concen-
trations of c-di-GMP has already been demonstrated by
transcriptional fusion analysis in heterologous system and by in
vitro assays for Cdi1_3 [15]. For the Cdi1_1 riboswitch located
upstream of the CD1990 gene encoding a conserved protein of
unknown function, we observed a 10-fold induction in 630/pdccA
strain as compared to control strain suggesting that this regulatory
RNA element functions through a mechanism different from that
used by other c-di-GMP type I riboswitches.
Functionality of c-di-GMP type II riboswitches. In vitro
and gene expression studies in a heterologous host suggest that the
expression of C. difficile genes regulated by type II c-di-GMP
riboswitches is induced in the presence of high c-di-GMP
concentrations by a complex mechanism of alternative splicing
positively modulating translation [13,14]. In our work, for two
type II c-di-GMP riboswitches examples shown in Figure 7D
(Cdi2_4 and Cdi2_3), the full-length transcript of the targeted
gene, CD3513 or CD2831, respectively, was observed in Northern
blots with probes hybridizing with riboswitch motif only in 630/
pdccA strain overexpressing CD1420, i.e., at conditions of elevated
c-di-GMP levels. Presumably, active translation of mRNA might
Table 3. Growth phase-regulated sRNAs.
Name
S/E fold
change Adjacent gene Strand 59_start Score Promoter 39_end Size, nt
Northern
blot, nt
Rfam
search
RCd4* 3.2 CD0550 membrane
protein
+ 655072 2.94 655670 598 0
SQ1002* 2.8 CD1518 feoA2 2 1761105 1.24 Sigma A TATAAT
17 bp TTGACA
1760892 213 200 0
RCd5* 199 CD1981 transcriptional
regulator
+ 2285913 14.43 Sigma A TATTAT
17 bp TTGAAA
2286311 398 GEMM RNA
motif
RCd2* 0.14 CD0183 cell wall
hydrolase
2 241078 1.19 Sigma A TATAGT
18 bp TTGTAA
240878 200 105, 150, 350 0
RCd6* 0.08 CD0470 blaR 2 560340 1.24 Sigma A TATATA
17 bp TTAAAT
560200 140 100 0
SQ1498* 0.1 CD2112 chp 2 2441927 1.51 -10 TATAAA 2441771 156 150 0
S, RNA extracted from cells at the onset of stationary phase (10 h of growth); E, RNA extracted from cells grown to exponential phase (4 h of growth). The S/E fold
change was determined by qRT-PCR analysis. The position of 59 start was identified by 59-end RNA-seq analysis with indicated score corresponding to the read length
(51 bases) coverage ratio for TAP+ and TAP2 sample. The position of 39-end was deduced from RNA-seq data.
*The positions of 59-start and/or 39-end of these sRNAs were confirmed by 59RACE or 59/39RACE analysis (Table S4). The presence of 210 and 235 boxes for sigma A-
dependent promoters is shown. The size of the transcripts detected in Northern blot is indicated. RNA sequences were analysed for matches in Rfam database (http://
rfam.sanger.ac.uk/), ‘‘0’’, no matches. ‘‘chp’’ conserved hypothetical protein.
doi:10.1371/journal.pgen.1003493.t003
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lead to stabilization of the full-length transcript. Conversely, at low
c-di-GMP concentrations, the translation of mRNA might be
inhibited leading to transcript destabilization. Several bands of
smaller size detected under all conditions tested could correspond
either to stable spliced forms or to forms produced by GTP attack
[13,14]. qRT-PCR analysis confirmed the c-di-GMP-dependent
positive control for all four type II c-di-GMP riboswitches with up
to 10-fold change of expression levels between 630/pdccA and
630/p strains (Figure 7B, Table S7). In addition, the correspond-
ing genes were only barely expressed both during exponenthial
growth and at the onset of stationary phase in liquid culture
(Figure 7D). The overexpression of CD1420 led to a greatly
increased biofilm formation (Figure 7B) and cell aggregation (data
not shown). The genes positively regulated by c-di-GMP through
type II riboswitches encode putative pilin, and adhesion and
surface proteins that could be involved in biofilm formation
(Figure 7B). In accordance with phenotypic changes induced by c-
di-GMP (Figure 7B), we hypothesize that C. difficile ensures
coordinated control of motility and biofilm formation and other
related processes through this use of two distinct - type I and type
II - riboswitches responding to the same molecule, c-di-GMP.
Altogether, our data provide experimental evidence for the
functionality of c-di-GMP riboswitches in C. difficile and further
highlight the crucial role of this second messenger in this pathogen.
Identification and expression analysis of CRISPR loci
Our deep sequencing analysis revealed the expression of an
additional class of regulatory RNAs, CRISPR RNAs, the products
of a recently discovered prokaryotic adaptive immunity system for
defense against foreign nucleic acids [8]. CRISPR arrays (also
called ‘‘cassettes’’) are composed of almost identical direct repeats
separated by similarly sized variable sequences called spacers that
often match viral or plasmid DNA. A CRISPR array is transcribed
into a single RNA transcript (pre-crRNA), which is cleaved by the
associated Cas proteins to generate small CRISPR RNAs
(crRNAs). Mature crRNAs bind Cas proteins and serve as guides
to recognize foreign nucleic acids by complementary base-pairing
(Figure 8A). This recognition leads to degradation of target nucleic
acid and protection of bacterial cell from invasion by foreign
DNA.
CRISPRdb database predicted the existence of 12 CRISPR
cassettes in the genome of C. difficile 630 strain with a variable
number of conserved 29-bp direct repeats separated by 37-bp
spacers [61]. Only two cassettes (CRISPR 12 and CRISPR 17) are
associated with cas genes. CRISPR 17 cassette carries the largest
number of spacers and is associated with a complete set of cas
genes; CRISPR 12 is associated with an incomplete cas gene set
(Table S8). According to the recent classification of CRISPR-Cas
systems, C. difficile posseses a Type I-B (subtype CASS7) CRISPR-
Cas system [62]. The high sequence conservation among repeats
suggests that RNA transcribed from CRISPR cassettes lacking
associated cas genes might be processed by Cas proteins encoded
by the operons associated with CRISPR 12 and/or 17. Our RNA-
seq analysis revealed the expression of all 12 CRISPR loci in C.
difficile 630Derm. 59-end RNA-seq analysis allowed precise identi-
fication of the TSS for all CRISPR cassettes and most of them
were associated with potential sigma A-dependent promoters
(Table S8). In all cases, the presence of a ‘‘leader’’ 59 region
located between the TSS and the first repeat of CRISPR cassette
was observed (Figure 8A, Figure S5).
Five C. difficile CRISPR cassettes are located within prophage
regions, and three of them are highly expressed (Table S8) as
exemplified by Northern blotting for CRISPR 16 cassette in
Figure 8B. Using a probe complementary to the first spacer
sequence of CRISPR 16, we can clearly distinguish, by Northern
blotting, full-length pre-crRNA transcripts of up to 1000 nt in
length, incompletely processed crRNA of various sizes, and,
finally, ,66-nt mature crRNA (Figure 8B). The apparent size of
the largest transcript detected in Northern blotting (Table S8,
Figure 8B, Figure S5) suggested that CRISPR 15 and 16 cassettes
may be co-transcribed. In fact, this entire region is duplicated in
the C. difficile 630 genome (giving raise to CRISPR 3 and 4, and
CRISPR 15 and 16 cassettes, Table S8). The 59-end RNA-seq and
RNA-seq profile for CRISPR 15/16 locus is shown in Figure S5,
the number of distinct read patterns is in accordance with the
number of repeats in the locus.
The deep sequencing data indicated that crRNAs from the
‘‘leader’’-proximal regions of CRISPR loci (Figure S5) were more
abundant than crRNAs encoded further downstream, as it was
also observed in Pyrococcus furiosus [63]. This gradient may reflect
differences in transcription, processing, and/or stability. This
observation raises then a question about the relevance of such
differential crRNA expression level for the functional activity and
dynamics of CRISPR-Cas system, where the most recently
acquired spacers are located next to the ‘‘leader’’ region [64]. In
addition, the deep sequencing profile and the size of crRNAs
detected by Northern blot are both in accordance with a recently
published cleavage pattern for a CRISPR-Cas subtype I-B [65].
Our experimental detection of crRNAs is the first demonstration
of the existence of multiple CRISPR cassettes expressed in
pathogenic clostridia in contrast to the presence of silent or only
barely expressed additional CRISPR loci reported in some other
bacteria including S. pyogenes and E. coli [66,67].
The presence of several functional CRISPR cassettes showing
different level of expression raises a question on the respective role
of each CRISPR in effective invader defense under different
conditions. Among the interesting features of the CRISPR-Cas
system in C. difficile, the location of some CRISPR arrays within
prophage regions suggests an efficient strategy for use of CRISPR
to limit the dispersal of competing phages [68].
Conclusion
In this study, we combined in silico predictions, global high-
throughput sequencing, and gene-targeted experimental ap-
proaches to identify sRNAs in the human pathogen C. difficile. A
total of about 250 sRNAs including sRNAs from IGRs, cis-
antisense RNAs, and riboswitches are experimentally detected in
this pathogen. This number is close to 200–300 sRNA genes
estimated to be present in an average bacterial genome [69].
However, the number revealed by our work is almost certainly an
underestimation, since some RNA regulators could be expressed at
conditions other than those analysed in our work. Since only a
small fraction of sRNAs identified in this study belongs to known
functional families, the majority of discovered C. difficile sRNAs
could represent novel riboregulators.
In contrast to Gram-negative bacteria, the conservation of
sRNAs seems to be mostly confined to the genus or even species
level in Gram-positive bacteria as has been recently shown for B.
subtilis SR1 homologues [40,70,71]. In accordance with these
observations, most of sRNAs identified in this study are common
to C. difficile strains but are absent from other clostridia. This may
be explained by very high heterogeneity of the Clostridium group,
which is a consequence of a wide variety of ecological niches and
distinct evolutionary pathways followed by different clostridial
species. Thus, our results further underscore the importance of
searches for regulatory RNAs in individual bacterial species for a
better understanding of their role in the physiology and the
infection cycle control. Moreover, the discovery of novel sRNAs
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by our approaches emphasizes the potential diversity of sRNAs in
clostridia.
Several features of newly identified sRNAs suggest the
importance and diversity of RNA-based mechanisms controlling
key steps during infection cycle of C. difficile. The presence of a
great number of functional riboswitches suggests a wide use of 59-
cis-RNA regulatory elements that ensure rapid and adequate
response of C. difficile to changing conditions allowing better
adaptation of metabolic pathways. Here, we demonstrated the
functionality of a particular class of such riboregulators, ribos-
witches responding to c-di-GMP. In most microorganisms,
proteins are effectors for c-di-GMP signaling pathways. In C.
difficile, the use of RNA riboswitches as effectors sensing c-di-GMP
further supports the importance of RNA-based regulatory
mechanisms in this bacterium. These riboswitches might be
important for coordinated control of many processes crucial for
successful development of C. difficile inside the host such as
adhesion, colonization, biofilm formation, motility and other
related processes.
Several sRNAs discovered in this study showed growth phase-
dependent expression profile being either induced or repressed
during transition from exponential growth to stationary phase.
This includes an interesting case of an IGR-located cis-antisense
RNA overlapping two adjacent genes that may be involved in the
control of autolytic activity in C. difficile. The synthesis of virulence
determinants and associated factors in C. difficile is also growth
phase-dependent [26,45,46]. One can speculate that some of
growth phase-regulated C. difficile sRNAs may be involved in this
control, as previously observed in other Gram-positive and in
Gram-negative bacteria [3,27,72].
An important finding of this work is the demonstration that
multiple CRISPR arrays are expressed in C. difficile. Foreign DNA
defense capacities provided by CRISPR-Cas system might be
important for C. difficile survival within bacteriophage-rich gut
communities and also for the control of genetic exchanges favored
within gut microbiota [73–75].
In summary, this study constitutes a first step towards better
understanding of complex sRNA-based regulatory networks
governing C. difficile physiology and pathogenesis. Further
investigations based on our findings will help to determine the
exact biological roles of many of these sRNAs and to uncover the
diverse molecular mechanisms of RNA-based regulation employed
by C. difficile to adapt to various environments it encounters outside
and inside the host.
Materials and Methods
Plasmid and bacterial strain construction and growth
conditions
C. difficile strains and plasmids used in this study are presented in
Table S6. C. difficile strains were grown anaerobically (5% H2, 5%
CO2, and 90% N2) in TY [76] or Brain Heart Infusion (BHI,
Difco) media, which was used for conjugation. When necessary,
Cefoxitin (Cfx; 25 mg/ml) and Thiamphenicol (Tm; 15 mg/ml)
were added to C. difficile cultures. E. coli strains were grown in
Luria-Bertani (LB) broth, and when indicated, ampicillin (100 mg/
ml) or chloramphenicol (15 mg/ml) was added to the culture
medium. The non-antibiotic analog anhydrotetracycline (ATc;
250–500 ng/ml) was used for induction of the Ptet promoter of
pRPF185 vector derivatives in the C. difficile [77].
Motility was tested on semi-solid BHI medium (0.17% agar)
containing 8 mg/ml Tm and 500 ng/ml ATc. Strains were
inoculated into semi-solid medium tubes and incubated for at
least 24 h at 37uC. Biofilm formation was assayed as previously
described [78].
All routine plasmid constructions were carried out using
standard procedures [79]. All primers used in this study are listed
in Table S9. For inducible expression of C. difficile genes, we used
the pRPF185 vector expression system carrying a gusA gene
between an ATc-inducible Ptet promoter and a transcriptional
terminator [77]. The SQ1498 region (26 to +272 relative to the
TSS of the sRNA), RCd6 (22 to +146), RCd2 (+1 to +391) and
the CD1420 gene (215 to +843 relative to the translational start
site) were amplified by PCR. To investigate the effects of down-
regulation of expression of SQ1498, RCd6 and RCd2, antisense
fragment to these sRNA genes was also cloned under the control of
the inducible Ptet promoter. We used primers containing a 59-
BamHI or a 39-SacI site for sense and 59-SacI or a 39-BamHI site
for antisense cloning orientation. These fragments were inserted
between the BamHI and SacI sites of pRPF185 vector. For sRNA
overexpression the pRPF185 vector was modified by reverse PCR
approach with OS618 and OS620 primers to allow cloning of
sRNA region directly between Ptet promoter and vector-borne
terminator. The CD0183 gene was cloned into StuI and BamHI
sites of pRPF185DgusA derivative carrying SacI, StuI, XhoI and
BamHI cloning sites instead of gusA region. DNA sequencing was
performed to verify plasmid constructs using pRPF185 specific
primers IMV507, OS621 and IMV508. The resulting derivative
pRPF185 plasmids were transformed into the E. coli HB101 (RP4)
and subsequently mated with C. difficile 630Derm [80] (Table S6).
C. difficile transconjugants were selected by sub-culturing on BHI
agar containing Tm (15 mg/ml) and Cfx (25 mg/ml).
RNA extraction, quantitative real-time PCR, and Northern
blot analysis
Total RNA was isolated from C. difficile 630Derm strain grown in
TY medium either after 4 h, 6 h or 10 h of growth and from
R20291 strain during late exponential growth phase (6 h) as
previously described [22]. Starvation conditions correspond to a
1 h incubation of exponentially grown cells (6 h of growth) in PBS
buffer at 37uC. Strains carrying pRPF185 derivatives were grown
in TY medium in the presence of 250–500 ng/mL ATc and
7.5 mg/mL Tm for 7.5 h followed by RNA isolation. The cDNA
synthesis by reverse transcription and quantitative real-time PCR
analysis was performed as previously described [45]. In each
sample, the relative expression for a gene was calculated relatively
to the 16S gene [81]. The relative change in gene expression was
recorded as the ratio of normalized target concentrations (DDCt)
[82]. Strand-specific RT-PCR analysis was performed as previ-
ously described [27].
For Northern blot analysis, 5 mg of total RNA was separated on
a denaturing 6% or 8% polyacrylamide gel containing 8 M urea,
and transferred to Hybond-N+ membrane (Amersham) by
electroblotting using the Trans-blot cell from Bio-Rad in 16
TBE buffer (89 mM Tris-base, 89 mM boric acid and 2 mM
EDTA). Following UV-cross-linking of the samples to the
membrane, prehybridization was carried out for 2 h at 42uC in
7 mL of prehybridization buffer ULTRAHyb (Ambion). Hybrid-
ization was performed overnight at 42uC in the same buffer in the
presence of a [gamma-32P]-labeled DNA oligonucleotide probe.
Alternatively, the probe was synthesized using PCR with 59end-
labeled primer complementary to RNA sequence. After hybrid-
ization, membranes were washed twice for 5 min in 50 mL 26
SSC (300 mM sodium chloride and 30 mM sodium citrate) 0.1%
sodium dodecyl sulphate (SDS) buffer and twice for 15 min in
50 mL 0.16 SSC 0.1% SDS buffer. Radioactive signal was
detected with a Typhoon system (Amersham). The size of the
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transcripts was estimated by comparison with RNA molecular
weight standards (Invitrogen).
59RACE and 59/39RACE
59RACE (Rapid amplification of cDNA ends) assays were
performed on total RNA extracted from C. difficile 630Derm strain
using a 59RACE System kit (Invitrogen) as previously described
[22]. 59/39RACE was performed essentially as previously
described [60] with some modifications. Total RNA (5 mg) was
treated with TAP (Epicentre) for 1 h at 37uC. After phenol/
chloroform extraction, followed by ethanol precipitation, RNA
was circularized with T4 RNA ligase (Biolabs) overnight at 16uC.
Circularized RNA was again extracted with phenol/chloroform,
ethanol precipitated and subjected to RT–PCR across the 59/39
junction. The PCR products were then cloned using the pGEM-T
easy system (Promega) and sequenced.
RNA–seq and 59-end RNA–seq experiments
Non-orientated library for whole transcript analysis by RNA-
seq was realized on the RNA sample extracted from C. difficile
630Derm strain during late exponential growth phase (6 h) as
previously described [83]. TAP converts 59-triphosphates into 59-
monophosphates allowing Illumina adaptor ligation to RNA 59-
ends before cDNA synthesis and thus the enrichment with primary
transcript reads. The TAP+ and TAP- library construction for
high-throughput sequencing (differential 59-end RNA-seq) was
realized on a mixed sample combining RNAs extracted from three
different growth conditions including exponential growth (4 h),
entry to stationary phase (10 h) and nutriment starvation (1 h
incubation in PBS buffer). 15 mg of total RNA treated with
TurboDNAse (Ambion) was used for depletion of ribosomal RNA
with the MicrobExpress kit (Ambion) following the manufacturer
instructions. RNA depleted for rRNA was divided into two similar
fractions and 1500 ng of this partially purified mRNAs was used
for each library preparation. To convert the 59PPP ends in 59P
ends, RNA was denatured 10 min at 65uC, placed on ice and
incubated 1 h at 37uC with 10 units of TAP (Epicentre) (TAP+
library). For TAP- library construction, RNA depleted for rRNA
was incubated with buffer alone under the same conditions.
Products were purified by phenol/chloroform extraction and
ethanol precipitation. cDNA library construction for Illumina
sequencing was performed as previously described [72]. 51-bp
sequences were generated via Illumina HiSeq 2000 sequencing
machine.
Sequencing data processing
The Illumina reads were first scanned for adaptor removal.
Remaining sequencing reads were mapped to the C. difficile
genome using Bowtie software (Options –sam -q -k 2000) [84] then
converted into BAM files with the Samtools script [85] (Table S2).
The data were visualized at a strand-specific manner (for 59-end
RNA-seq libraries) or as a whole transcript coverage map (for
RNA-seq) using COV2HTML (Marc Monot, submitted). All
TSSs detected by 59-end RNA-seq were inspected manually to
identify potential sRNAs. To estimate the relevance of each TSS, a
score was computed which corresponds to the read length (51
bases) coverage ratio for sample with and without TAP treatment
(Table S3). The transcript length of sRNAs was estimated by
scanning the read coverage, produced by the whole-transcript
sequencing (RNA-seq), downstream to the identified 59-end. A
sharp decline in the read coverage was considered the 39-end of
the transcript. In the absence of alternative experimental data for
antisense transcripts overlapping coding regions or for barely
detected transcripts the arbitrary length was fixed to 100 nt (Table
S3).
In silico screening for new sRNA genes and their feature
analysis
The in silico screening of the genome of C. difficile 630 strain was
done as previously described for S. agalactiae [27]. Briefly, the Rho-
independent terminators were predicted along the full genome
sequence with Transterm HP software with default parameters.
Comparative genomics of the C. difficile 630 strain was done
against all available sequences of clostridial strains in the GenBank
database (March 2010). The prediction of secondary structure of
each sRNA candidate was performed with Mfold 3.4 software
[42]. All other steps were done as described without modifications.
To analyse possible coding capacities of sRNAs their sequences
were scanned for the presence of protein coding sequences (CDSs)
starting with ATG, TTG or GTG codons representing almost the
totality of start codons identified in C. difficile genome [86]. The
size of CDSs was limited to 45 bases without stop codon (TAG,
TAA or TGA). Detected CDSs were analysed for the presence of
putative ribosome binding site by searching Shine-Dalgarno
sequences within 20 nucleotides upstream of start codon. Predicted
CDSs were also tested using BLASTP for similarity with known
proteins (E-value of 0.05 or less) and CDSs sized greater than 15
amino acids with no homologues were classified as possible novel
proteins or peptides.
The conservation of sRNAs detected in this study was
determined by comparing them with sequence homologues in 13
C. difficile, 14 other clostridial genomes and 5 additional bacterial
genomes outside Clostridia. We used BLAST with standard
parameters and selected matches corresponding to the alignments
covering more than 80% of sRNA length (E-value of 0.001 or less).
We performed a search for riboswitch conservation in the
upstream regulatory regions of the orthologous genes from C.
difficile strains (80% bidirectional orthology criteria) and other
clostridial species (30% bidirectional orthology criteria) and
selected matches corresponding to BLAST alignments covering
more than 80% of riboswitch length for C. difficile strains and
.30% for the other clostridia. The ORF conservation within C.
difficile strains was analyzed by TBLASTX with standard
parameters.
The Rfam database was used to search for known sRNAs [34].
In order to predict target mRNA for the identified sRNAs
TargetRNA [87], IntaRNA [88] and RNAPredator [89] servers
were used with standard parameters. The overlapping predictions
with highest score were considered for experimental validation.
Data access
Deep sequencing data are available at http://mmonot.eu/
COV2HTML/visualisation.php?str_id = -13.
Supporting Information
Figure S1 Experimental validation of in silico predicted sRNAs.
RT-PCR was performed using gene-specific primers (Table S9) for
SQ1002 (lanes 1 and 2), SQ2025 (lanes 3 and 4), SQ0367 (lanes 5
and 6), SQ0931 (lanes 7 and 8), SQ1498 (lanes 9 and 10), with
RNA extracted from 630Derm cells grown to exponential phase
(4 h of growth) (lanes 1, 3, 5, 7 and 9) or to the entry to stationary
phase (10 h of growth) (lanes 2, 4, 6, 8 and 10). Negative control
reactions without reverse transcriptase performed using the same
gene-specific primers and RNA samples are shown in lanes 11–20.
(PDF)
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Figure S2 Detection of abundant 6S RNA by deep sequencing.
The TAP2/TAP+ profile comparison for 59-end RNA-seq data is
aligned with RNA-seq data for RCd3 (6S RNA) genomic region.
The TSS identified by 59-end sequencing are indicated by red
broken arrows in accordance with the positions of 59-transcript
ends shown by vertical green lines on the sequence read graphs
corresponding either to TSS (broken arrows) or to processing sites
(vertical arrows). TSS corresponds to position with significantly
greater number of reads in TAP+ sample, potential cleavage site
corresponds to position with large number of reads in both TAP2
and TAP+ samples. 59-end sequencing data show 51-bp reads
matching to the 59-transcript ends, while RNA-seq data show
reads covering whole transcript. Coding sequences are indicated
by blue arrows and the 6S RNA is indicated by a grey arrow.
(PDF)
Figure S3 Expression analysis by deep sequencing of growth
phase-regulated sRNAs. The results are given at the left for RCd6
sRNA and at the right for SQ1498. The TAP2/TAP+ profile
comparison for 59-end RNA-seq data is aligned with RNA-seq
data for corresponding genomic region. The TSS identified by 59-
end sequencing are indicated by red broken arrows in accordance
with the positions of 59-transcript ends shown by vertical green
lines on the sequence read graphs corresponding either to TSS
(broken arrows) or to processing sites. TSS corresponds to position
with significantly greater number of reads in TAP+ sample. 59-end
sequencing data show 51-bp reads matching to the 59-transcript
ends, while RNA-seq data show reads covering whole transcript.
Coding sequences are indicated by blue arrows and new sRNA
candidates identified in this study are indicated by grey arrows.
(PDF)
Figure S4 Co-transcription of SQ173 and flgB operon. TAP2/
TAP+ (59-end RNA-seq) profile comparison and RNA-seq data
are given for SQ173 located upstream of the flgB flagella operon.
The positions of the primers used for RT-PCR are indicated at the
bottom of the flgB region diagram with the estimated length of
corresponding fragments. RT-PCR was performed using gene-
specific primers (Table S9) for SQ173 (Cdi1_3) and flgB with RNA
extracted from 630Derm cells grown to exponential phase (4 h of
growth) (lanes 1, 2, 3) or to the entry to stationary phase (10 h of
growth) (lanes 4, 5, 6). Negative control reactions without reverse
transcriptase performed using the same gene-specific primers and
RNA samples are shown in lanes 7–12.
(PDF)
Figure S5 Expression analysis of CRISPR 16 cassette by deep
sequencing. The TAP2/TAP+ profile comparison for 59-end
RNA-seq is aligned with RNA-seq data for corresponding
genomic region. The TSS identified by 59-end sequencing are
indicated by red broken arrows in accordance with the positions of
59-transcript ends shown by vertical green lines on the sequence
read graphs corresponding either to TSS (broken arrows) or to
processing sites. TSS corresponds to position with significantly
greater number of reads in TAP+ sample, potential cleavage site
corresponds to position with large number of reads in both TAP2
and TAP+ samples. 59-end sequencing data show 51-bp reads
matching to the 59-transcript ends, while RNA-seq data show
reads covering whole transcript.
(PDF)
Table S1 Complete list of predicted sRNAs.
(PDF)
Table S2 Summary of sequenced 51-bp reads from NGS of C.
difficile.
(PDF)
Table S3 Complete list of sRNA detected by deep sequencing.
(PDF)
Table S4 sRNA extremity identification by 59RACE and 59/
39RACE.
(PDF)
Table S5 Conservation of regulatory RNAs in bacterial strains.
(PDF)
Table S6 Strains and plasmids used in this study.
(PDF)
Table S7 C-di-GMP riboswitches.
(PDF)
Table S8 CRISPR arrays.
(PDF)
Table S9 Oligonucleotides used in this study.
(PDF)
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